Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weimar

Showing results (271-280 of 436) with videos related to

Pageof 44
Sort By:
Transplantation Proceedings|February 1, 1995
Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipientsT van Gelder, C J Knoop, C J Hesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Low-density lipoprotein oxidation is increased in kidney transplant recipientsM A van den Dorpel, H Ghanem, J Rischen-Vos, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised studyA H Balk, K Meeter, M L Simoons, et al.
Nephron|January 1, 1995
High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration: metabolic control and outcome in sixty patientsE F van Bommel, N D Bouvy, K L So, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Patterns in donor-specific mRNA and protein production of Th1 and Th2 cytokines by graft-infiltrating lymphocytes and PBMC after heart transplantationC C Baan, N M van Besouw, C R Daane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
The influence of cholesterol on mortality after transplantation is age dependentJ I Roodnat, P G Mulder, R Zietse, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat modelF B Oei, M J Welters, L M Vaessen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 1, 1993
Coronary artery disease after heart transplantation: timing of coronary arteriographyA H Balk, M L Simoons, M J vd Linden, et al.
Pageof 44

Showing results (271-280 of 436) with videos related to

Sort By:
Pageof 44
Transplantation Proceedings|February 1, 1995
Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipientsT van Gelder, C J Knoop, C J Hesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Low-density lipoprotein oxidation is increased in kidney transplant recipientsM A van den Dorpel, H Ghanem, J Rischen-Vos, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised studyA H Balk, K Meeter, M L Simoons, et al.
Nephron|January 1, 1995
High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration: metabolic control and outcome in sixty patientsE F van Bommel, N D Bouvy, K L So, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Patterns in donor-specific mRNA and protein production of Th1 and Th2 cytokines by graft-infiltrating lymphocytes and PBMC after heart transplantationC C Baan, N M van Besouw, C R Daane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
The influence of cholesterol on mortality after transplantation is age dependentJ I Roodnat, P G Mulder, R Zietse, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat modelF B Oei, M J Welters, L M Vaessen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 1, 1993
Coronary artery disease after heart transplantation: timing of coronary arteriographyA H Balk, M L Simoons, M J vd Linden, et al.
Pageof 44